In July 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4134 (the Athlete) after his sample tested positive for the prohibited substance Methylephedrine. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.
The Athlete admitted that he had used an over-the-counter medication as treatment for his cough on the day before the sample collection.
The Panel finds that the violation was non intentional and that the Athlete had failed to duly research the ingredients of the medication before using because the label of the medication clearly mentioned the prohibited substance dl methylephedrine hydrochloride.
Considering the Athletes negligence the Japan Anti-Doping Disciplinary Panel decides on 1 August 2012 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 25 July 2012.
